Regulation

Open Access
Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Adrian R. Levy, David Stock, J. Michael Paterson, Hala Tamim, Dan Chateau, Jacqueline Quail, Paul E. Ronksley, Greg Carney, Pauline Reynier and Laura Targownik; for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators

November 07, 2023 11 (6) E1033-E1040; DOI: https://doi.org/10.9778/cmajo.20220131
Open Access
Abortion services and providers in Canada in 2019: results of a national survey
Regina M. Renner, Madeleine Ennis, Damien Contandriopoulos, Edith Guilbert, Sheila Dunn, Janusz Kaczorowski, Elizabeth K. Darling, Arianne Albert, Claire Styffe and Wendy V. Norman

September 27, 2022 10 (3) E856-E864; DOI: https://doi.org/10.9778/cmajo.20210232
Open Access
The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis
Charlotte G. Boone, Tony Antoniou, David N. Juurlink, Teagan Rolf von den Baumen, Sophie A. Kitchen, Georgia C. Richards, Mina Tadrous and Tara Gomes

December 14, 2021 9 (4) E1181-E1186; DOI: https://doi.org/10.9778/cmajo.20210173
Open Access
Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study
Jennifer Fenna, Cherry Chu, Rola Hassan, Tara Gomes and Mina Tadrous

December 07, 2021 9 (4) E1128-E1133; DOI: https://doi.org/10.9778/cmajo.20200232
Open Access
Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
Mina Tadrous, Benjamin Daniels, Sallie-Anne Pearson and Tara Gomes

November 23, 2021 9 (4) E1048-E1054; DOI: https://doi.org/10.9778/cmajo.20200291
Open Access
Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
Tara Gomes, Daniel McCormack, Sophie A. Kitchen, J. Michael Paterson, Muhammad M. Mamdani, Laurie Proulx, Lorraine Bayliss and Mina Tadrous

November 23, 2021 9 (4) E1055-E1062; DOI: https://doi.org/10.9778/cmajo.20210091
Open Access
Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study
Jeremy Y. Ng, Kevin Gilotra, Sana Usman, Yaping Chang and Jason W. Busse

April 13, 2021 9 (2) E342-E348; DOI: https://doi.org/10.9778/cmajo.20200187
Open Access
Association between legalization of recreational cannabis and fatal motor vehicle collisions in the United States: an ecologic study
Sarah B. Windle, Mark J. Eisenberg, Pauline Reynier, Josselin Cabaussel, Brett D. Thombs, Roland Grad, Carolyn Ells, Crystal Sequeira and Kristian B. Filion

March 17, 2021 9 (1) E233-E241; DOI: https://doi.org/10.9778/cmajo.20200155
You have access
Pediatric drug data in Canadian drug monographs: a descriptive analysis
Preeya Raja, Mark Duffett, Maryann Mazer-Amirshahi, Ashaka Patel, Andrea Gilpin, Catherine Litalien, Anthony K. Chan, John van den Anker, Thierry Lacaze-Masmonteil and Samira Samiee-Zafarghandy

August 31, 2020 8 (3) E522-E529; DOI: https://doi.org/10.9778/cmajo.20200010
You have access
Factors associated with drug shortages in Canada: a retrospective cohort study
Wei Zhang, Daphne P. Guh, Huiying Sun, Larry D. Lynd, Aidan Hollis, Paul Grootendorst and Aslam H. Anis

August 31, 2020 8 (3) E535-E544; DOI: https://doi.org/10.9778/cmajo.20200036

Main menu

User menu

Search

Regulation

Pages

Content

About